Furthermore, it has been reported that the progression of hyperlipidemia-related diseases such as atherosclerosis, nonalcoholic fatty liver disease (NAFLD), and obesity are mediated by STAT3 and NF-κB due to upregulation of miR-155 expression [104]. This evidence concerns the gene STAT3 and metabolic dysfunction-associated steatotic liver disease.